BTIG on Jade Biosciences (JBIO): 'We See Sentiment Continuing to Rise for APRIL Inhibitors in IgAN'
Tweet Send to a Friend
BTIG analyst Julian Harrison reiterated a Buy rating and $28.00 price target on Jade Biosciences (NASDAQ: JBIO).The analyst comments "Biomarker-rich ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
